Uploaded November 2025 | Updated September 2026, 2 weeks ago
In this lecture, Bethany Cummings, D.V.M., Ph.D., professor at the UC Davis School of Medicine, explores how GLP-1 (glucagon-like peptide-1) works as a powerful metabolic hormone and why GLP-1 medications like semaglutide, liraglutide, and tirzepatide are transforming the treatment of obesity, type 2 diabetes, and metabolic disease. Dr. Cummings explains the science behind GLP-1 receptor agonists, including how they regulate insulin secretion, slow digestion, reduce appetite, and improve cardiovascular health. She also discusses the history of GLP-1 drug development, advances in oral GLP-1 therapies, next-generation multi-agonists, and how nutrition and metabolism play a role in optimizing GLP-1–based treatments and long-term metabolic health.
"The Science of Metabolic Hormones: Precision Nutrition in the 'Ozempic Era”' is a forum that took place at UC Davis' Sacramento campus on October 6-7, 2025. Guided by leading UC Davis researchers, the forum explored how deep scientific understanding of metabolic hormones like GLP-1s can inspire a new wave of innovation—shaping the future of food for health in meaningful, lasting ways.
Watch more lectures from this series: youtube.com/playlist?list=PLM7qvIv8N9Rs9ZS45aOkKzekHGnothOE4
Learn more about GLP-1 and health: https://health.ucdavis.edu/news/headlines/glp-1-and-health-beyond-weight-loss-in-the-ozempic-era/2025/11
UC Davis Center for Alimentary and Metabolic Science: https://health.ucdavis.edu/surgery/research/alimentary-metabolic/
UC Davis Innovation Institute for Food and Health: https://foodandhealth.ucdavis.edu/
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
This video includes an audio description track. To hear the narration of important on-screen information, turn on "English Descriptive" in the player’s settings menu.
The information in this video was accurate as of the recording date, 10/6/25. For information purposes only. Consult your local medical authority for advice.
#glp1 #glp1medications #ozempic #weightloss #ucdavis
In this lecture, Bethany Cummings, D.V.M., Ph.D., professor at the UC Davis School of Medicine, explores how GLP-1 (glucagon-like peptide-1) works as a powerful metabolic hormone and why GLP-1 medications like semaglutide, liraglutide, and tirzepatide are transforming the treatment of obesity, type 2 diabetes, and metabolic disease. Dr. Cummings explains the science behind GLP-1 receptor agonists, including how they regulate insulin secretion, slow digestion, reduce appetite, and improve cardiovascular health. She also discusses the history of GLP-1 drug development, advances in oral GLP-1 therapies, next-generation multi-agonists, and how nutrition and metabolism play a role in optimizing GLP-1–based treatments and long-term metabolic health.
"The Science of Metabolic Hormones: Precision Nutrition in the 'Ozempic Era”' is a forum that took place at UC Davis' Sacramento campus on October 6-7, 2025. Guided by leading UC Davis researchers, the forum explored how deep scientific understanding of metabolic hormones like GLP-1s can inspire a new wave of innovation—shaping the future of food for health in meaningful, lasting ways.
Watch more lectures from this series: youtube.com/playlist?list=PLM7qvIv8N9Rs9ZS45aOkKzekHGnothOE4
Learn more about GLP-1 and health: https://health.ucdavis.edu/news/headlines/glp-1-and-health-beyond-weight-loss-in-the-ozempic-era/2025/11
UC Davis Center for Alimentary and Metabolic Science: https://health.ucdavis.edu/surgery/research/alimentary-metabolic/
UC Davis Innovation Institute for Food and Health: https://foodandhealth.ucdavis.edu/
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
This video includes an audio description track. To hear the narration of important on-screen information, turn on "English Descriptive" in the player’s settings menu.
The information in this video was accurate as of the recording date, 10/6/25. For information purposes only. Consult your local medical authority for advice.
#glp1 #glp1medications #ozempic #weightloss #ucdavis
